Which dose of bevacizumab is more effective for the treatment of aggressive posterior retinopathy of prematurity: lower or higher dose?

Seyhan Dikci; Osman Melih Ceylan; Soner Demirel; Turgut Yılmaz

DOI: 10.5935/0004-2749.20180005

Department of Ophthalmology, İnönü University Turgut Özal Medical Center, Malatya, Turkey

Corresponding author

Seyhan Dikci
E-mail: [email protected]

Funding: No specific financial support was available for this study.

Disclosure of potential conflicts of interest: None of the authors have any potential conflict of interest to disclose.

Approved by the following research ethics committee: İnönü University Turgut Özal Medical Center (# 2016/9-4).

Read in Portuguese XML Print PDF English

How to cite this article:

Dikci S, Ceylan OM, Demirel S, Yılmaz T. Qual a dose de bevacizumab no tratamento da retinopatia da prematuridade posterior agressiva: menor ou maior dose?. Arq. Bras. Oftalmol. 2018;81(1):. 10.5935/0004-2749.20180005

Export citation